119 results
Page 4 of 6
8-K
EX-99.1
lvq5bmvs60
21 Jun 21
Regulation FD Disclosure
8:15am
8-K
qeav vafx8y9koy6x
21 Jun 21
Regulation FD Disclosure
8:15am
S-3ASR
jogm lkncy3mnddm3v3
18 May 21
Automatic shelf registration
6:01am
S-3ASR
EX-1.2
zwnaogp3p20
18 May 21
Automatic shelf registration
6:01am
8-K
EX-99.1
cjyp09cs882foy4q1u
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
p2qa3mg6m23s
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.2
ehl35g6giglesvt8ntyv
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
5uhewr37a2a 4tootxdv
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
jh6os qjpxf6w97
16 Mar 21
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
8:10am
8-K
zdq7puqil kxgnkdbb0z
12 Mar 21
Amendments to Articles of Incorporation or Bylaws
5:25pm
8-K
h59c2
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
EX-99.1
ugndq1v2kre7x
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
EX-99.1
84xm1z dy5o9pofi84
16 Nov 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation November 2020
6:30am
8-K
EX-99.1
1zp83e4vnpe548
12 Nov 20
Akero Therapeutics Reports THIRD Quarter 2020 Financial Results
4:20pm
8-K
EX-99.1
dmork
15 Oct 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation October 2020
8:30am
8-K
EX-99.1
ykn 0ap43i8f
12 Aug 20
Akero Therapeutics Reports SECOND Quarter 2020 Financial Results
4:25pm